Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry

Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry

Author: Mithun Nandy

Publisher: Springer Nature

Published: 2021-12-03

Total Pages: 224

ISBN-13: 981166921X

DOWNLOAD EBOOK

The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the ‘Pharmacy of the World’ and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as ‘Innovate in India and Serve to the World’. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach.


Corporate Crime in the Pharmaceutical Industry (Routledge Revivals)

Corporate Crime in the Pharmaceutical Industry (Routledge Revivals)

Author: John Braithwaite

Publisher: Routledge

Published: 2013-10-08

Total Pages: 451

ISBN-13: 1135072906

DOWNLOAD EBOOK

First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally.